Neurological Performance Supported by Research.
- Selank · Semax
- Investigational, US
- Nasal Spray or SubQ
- No Sedation · No Dependency Risk
Research-Backed. Clinician-Supervised. Fully Disclosed.
Anxiolytic Neuropeptide · GABA Modulation Research
Selank
Tuftsin Analogue · Heptapeptide · Developed at IMGB Moscow
Selank is a synthetic analogue of the endogenous immunopeptide Tuftsin, developed by the Institute of Molecular Genetics in Russia. Research data, primarily from Russian clinical studies, suggests potential anxiolytic, nootropic, and immune-modulating properties without the sedation or dependence associated with benzodiazepines. It is not FDA-approved in the United States. Compounding availability is subject to current regulations and is fully discussed at consultation.
Proposed mechanisms: GABA-A receptor sensitivity modulation · Serotonin and dopamine turnover regulation · Possible BDNF upregulation · Anti-anxiety effects in research models without sedation.
- Investigational in the US. Not FDA-approved. Research primarily from Russian studies, with methodological limitations disclosed at consultation. Compounding availability is subject to current FDA regulations.
Typical Administration
Nasal spray (primary) or subcutaneous injection · Daily protocol
Cognitive Enhancer · BDNF Stimulation Research
Semax
ACTH 4-7 Pro-Gly-Pro Analogue · Nootropic Neuropeptide
Semax is an analogue of ACTH 4–7 developed for cognitive enhancement and neuroprotection research. Studies have investigated its potential to upregulate BDNF (Brain-Derived Neurotrophic Factor), which is involved in neuronal growth, learning, and synaptic plasticity, making it of interest for memory support and cognitive resilience. Research is primarily from Eastern European studies, with limited randomized controlled trial data. It is investigational in the United States.
Proposed mechanisms: BDNF and NGF expression upregulation · Dopaminergic and serotonergic activity enhancement · Neuroprotective properties in research models.
- Investigational in the US. Not FDA-approved. Research base primarily Eastern European, with limitations disclosed at consultation. Subject to current FDA compounding regulations.
Typical Administration
Nasal spray (primary) · Daily or cycling protocols · Can be combined with Selank
Selank + Semax as a Cognitive Stack: When used together, Selank may address the anxiety and cortisol-driven cognitive impairment dimension while Semax may support BDNF-mediated cognitive enhancement. The combination is discussed at consultation, with full evidence review, regulatory status disclosure, and individual clinical assessment before any consideration.
Cognitive Peptides · Ann Arbor
Clarity Is a Clinical Goal. Not a Marketing Claim.
Schedule a cognitive performance consultation at Arbour Longevity. We review your neurological health, hormone status, and relevant biomarkers, and discuss which investigational compounds have evidence worth considering, what the limitations of that evidence are, and whether it is appropriate for your situation.
Regenerative medicine and aesthetic arts: where science meets the artistry of transformation.
.png)
